TLR7 and systemic lupus erythematosus: The TLR7 agonist IMQ-induced lupus mouse model was prepared as previously described.22 The results revealed that IMQ-treated mice exhibited lupus-like symptoms with marked splenomegaly (Supplementary Figure 1A, 1B) and severe proteinuria (Supplementary Figure 2C).